Controlled Substances: Adjustment to the Established 2014 Aggregate Production Quota for Marijuana, 25620-25621 [2014-10202]
Download as PDF
25620
Federal Register / Vol. 79, No. 86 / Monday, May 5, 2014 / Notices
applications for a particular OVW grant
program.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 200 individuals
participate in the OVW Peer Reviewer
Database.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated public burden
associated with this collection is 15
minutes. It is estimated that respondents
will take less than 15 minutes to
complete periodic and infrequent
submissions and updates to the
database. The burden hours for
collecting respondent data is 50 hours
(200 respondents × .25 hours = 50
hours).
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., 3E.405B,
Washington, DC 20530.
Dated: April 29, 2014.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2014–10125 Filed 5–2–14; 8:45 am]
BILLING CODE 4410–FX–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–378]
Controlled Substances: Adjustment to
the Established 2014 Aggregate
Production Quota for Marijuana
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice with request for
comments.
AGENCY:
This notice adjusts the
established 2014 aggregate production
quota for marijuana, a schedule I
controlled substance under the
Controlled Substances Act.
DATES: Effective date: May 5, 2014.
Comment date: Interested persons may
file written comments on this notice in
accordance with 21 CFR 1303.13.
Electronic comments must be submitted
and written comments must be
postmarked, on or before June 4, 2014.
Commenters should be aware that the
electronic Federal Docket Management
System will not accept comments after
midnight Eastern Time on the last day
of the comment period.
ADDRESSES: To ensure proper handling
of comments, please reference ‘‘Docket
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:56 May 02, 2014
Jkt 232001
No. DEA–378’’ on all electronic and
written correspondence. The DEA
encourages that all comments be
submitted electronically through the
Federal eRulemaking Portal which
provides the ability to type short
comments directly into the comment
field on the Web page or attach a file for
lengthier comments. Please go to https://
www.regulations.gov and follow the
online instructions at that site for
submitting comments. Paper comments
that duplicate electronic submissions
are not necessary. Should you, however,
wish to submit written comments, in
lieu of electronic comments, they
should be sent via regular or express
mail to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152.
FOR FURTHER INFORMATION CONTACT:
Ruth A. Carter, Office of Diversion
Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152, Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments
received in response to this docket are
considered part of the public record and
will be made available for public
inspection online at https://
www.regulations.gov. Such information
includes personal identifying
information (such as your name,
address, etc.) voluntarily submitted by
the commenter.
The Freedom of Information Act
(FOIA) applies to all comments
received. If you want to submit personal
identifying information (such as your
name, address, etc.) as part of your
comment, but do not want it to be made
publicly available, you must include the
phrase ‘‘PERSONAL IDENTIFYING
INFORMATION’’ in the first paragraph
of your comment. You must also place
all of the personal identifying
information you do not want made
publicly available in the first paragraph
of your comment and identify what
information you want redacted. If you
want to submit confidential business
information as part of your comment,
but do not want it to be made publicly
available, you must include the phrase
‘‘CONFIDENTIAL BUSINESS
INFORMATION’’ in the first paragraph
of your comment. You must also
prominently identify the confidential
business information to be redacted
within the comment. If a comment has
so much confidential business
information that it cannot be effectively
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
redacted, all or part of that comment
may not be made publicly available.
Comments containing personal
identifying information or confidential
business information identified as
directed above will be made publicly
available in redacted form.
An electronic copy of this document
is available at https://
www.regulations.gov for easy reference.
If you wish to personally inspect the
comments and materials received or the
supporting information the DEA used in
preparing this action, these materials
will be available for public inspection
by appointment. To arrange a viewing,
please see the FOR FURTHER INFORMATION
CONTACT paragraph above.
Pursuant to 21 CFR 1303.13, any
interested person may submit written
comments on or objections to this
notice. Based on comments received in
response to this notice, the
Administrator may hold a public
hearing on one or more issues raised in
the comments and objections filed. In
the event the Administrator decides to
hold such a hearing, the Administrator
shall publish notice of the hearing in the
Federal Register. After consideration of
any comments or objections, or after a
hearing, if one is held, the
Administrator shall issue and publish in
the Federal Register a notice regarding
the adjustment to the established 2014
aggregate production quota for
marijuana.1
Legal Authority
The Drug Enforcement
Administration (DEA) implements and
enforces titles II and III of the
Comprehensive Drug Abuse Prevention
and Control Act of 1970, as amended.
Titles II and III are referred to as the
‘‘Controlled Substances Act’’ and the
‘‘Controlled Substances Import and
Export Act,’’ respectively, and are
collectively referred to as the
‘‘Controlled Substances Act’’ or the
‘‘CSA’’ for the purpose of this action. 21
U.S.C. 801–971. The DEA publishes the
implementing regulations for these
statutes in title 21 of the Code of Federal
Regulations (CFR), parts 1300 to 1321.
The CSA and its implementing
regulations are designed to prevent,
detect, and eliminate the diversion of
controlled substances and listed
chemicals into the illicit market while
providing for the legitimate medical,
scientific, research, and industrial needs
of the United States. Controlled
substances have the potential for abuse
1 Note that ‘‘marihuana’’ is the spelling originally
used in the Controlled Substances Act (CSA). This
document uses the spelling that is more common
in current usage, ‘‘marijuana.’’
E:\FR\FM\05MYN1.SGM
05MYN1
25621
Federal Register / Vol. 79, No. 86 / Monday, May 5, 2014 / Notices
and dependence and are controlled to
protect the public health and safety.
Section 306 of the CSA (21 U.S.C.
826) requires the Attorney General to
establish aggregate production quotas
for each basic class of controlled
substance listed in schedules I and II
each year. The Attorney General has
delegated this authority under 21 U.S.C.
826 to the Administrator of the DEA, 28
CFR 0.100.
emcdonald on DSK67QTVN1PROD with NOTICES
Background
The DEA established the initial 2014
aggregate production quotas and
assessments for annual need on
September 9, 2013 (78 FR 55099). The
notice stipulated that, as provided for in
21 CFR 1303.13, all aggregate
production quotas and assessments for
annual need are subject to adjustment.
Analysis for Adjusting the Established
2014 Aggregate Production Quota for
Marijuana Effective on the Date of
Publication
In determining to adjust the aggregate
production quota, the DEA takes into
consideration, among other factors, the
relevant scientific and research needs of
the United States. 21 U.S.C. 826; 21 CFR
1303.13(b)(5).
The National Institute on Drug Abuse
(NIDA) is a component of the National
Institutes of Health and the U.S.
Department of Health and Human
Services, and it oversees the cultivation,
production and distribution of researchgrade marijuana on behalf of the United
States Government, pursuant to the
Single Convention on Narcotic Drugs
(March 30, 1961, 18 UST 1407). NIDA
recently notified the DEA that it
required additional supplies of
marijuana to be manufactured in 2014 to
provide for current and anticipated
research efforts involving marijuana.
Specifically, NIDA stated that 600
kilograms is necessary to be
manufactured in 2014.
The DEA was unaware of NIDA’s
additional need at the time the initial
aggregate production quota for
marijuana was established in September
2013.
The aggregate production quota for
marijuana should be increased in order
to provide a continuous and
uninterrupted supply of marijuana in
support of DEA-registered researchers
who are approved by the Federal
Government to utilize marijuana in their
research protocols.
In the event the established aggregate
production quota is increased, DEA
regulations require general notice of the
adjustment prior to adjusting the quota.
21 CFR 1303.13(c). Due to the
manufacturing process unique to
VerDate Mar<15>2010
17:56 May 02, 2014
Jkt 232001
marijuana, including the length of time
and conditions necessary to propagate
and process the substance for
distribution in 2014, it is necessary to
adjust the initial, established 2014
aggregate production quota for
marijuana as soon as practicable.
Accordingly, the Administrator finds
good cause to adjust the aggregate
production quota for marijuana before
accepting written comments from
interested persons or holding a public
hearing, pursuant to 21 CFR 1303.13(c).
More specifically, the Administrator
finds, based on NIDA’s aforementioned
submission to DEA, that it is in the
public interest to adjust the aggregate
production quota immediately to ensure
that the cultivation of marijuana to meet
NIDA’s anticipated needs to supply
researchers can proceed within the
current grow cycle. For this same
reason, the Administrator finds that
delaying the adjustment to the aggregate
production quota for marijuana until
after the comment period would be
impracticable. Any such comments
shall be considered if submitted in
accordance with the procedures
described herein.
In issuing this adjustment, the DEA
has taken into account the criteria that
the DEA is required to consider in
accordance with 21 CFR 1303.13(b). The
DEA determines whether to adjust the
aggregate production quotas for basic
classes of schedule I and II controlled
substances by considering: (1) Changes
in demand for the basic class, changes
in the national rate of net disposal for
the class, and changes in the rate of net
disposal by the registrants holding
individual manufacturing quotas for the
class; (2) whether any increased demand
or changes in the national or individual
rates of net disposal are temporary,
short term, or long term; (3) whether any
increased demand can be met through
existing inventories, increased
individual manufacturing quotas, or
increased importation, without
increasing the aggregate production
quota; (4) whether any decreased
demand will result in excessive
inventory accumulation by all persons
registered to handle the class; and (5)
other factors affecting the medical,
scientific, research, and industrial needs
of the United States and lawful export
requirements, as the Administrator finds
relevant.
Based on the above, the Administrator
adjusts the established 2014 aggregate
production quota for marijuana, to be
manufactured in the United States in
2014 to provide for the estimated
scientific, research, and industrial needs
of the United States, and the
establishment and maintenance of
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
reserve stocks, expressed in grams of
anhydrous acid or base, as follows:
Basic class—
schedule I
Previously
established
2014 quota
(g)
Adjusted
2014 Quota
(g)
Marijuana ..........
21,000
650,000
Dated: April 29, 2014.
Michele M. Leonhart,
Administrator.
[FR Doc. 2014–10202 Filed 5–2–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Comment Request for Information
Collection for Form ETA–9089,
Application for Permanent
Employment Certification (OMB
Control Number 1205–0451), Extension
of Currently Approved Collection
Employment and Training
Administration (ETA), Labor.
ACTION: Notice.
AGENCY:
The Department of Labor
(DOL), as part of its continuing effort to
reduce paperwork and respondent
burden, conducts a preclearance
consultation program to provide the
public and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995 (44
U.S.C. 3506(c)(2)(A)). This program
helps ensure that requested data can be
provided in the desired format,
reporting burden (time and financial
resources) is minimized, collection
instruments are clearly understood, and
the impact of collection requirements on
respondents can be properly assessed.
Currently, ETA is soliciting comments
concerning the collection of data about
Form ETA–9089, Application for
Permanent Employment Certification
(OMB Control Number 1205–0451),
which expires August 31, 2014. The
form is used in DOL’s employmentbased immigration program by
employers to request permission to
bring foreign workers to the United
States as immigrants, and in the
Department of Homeland Security’s
National Interest Waiver (NIW) program
by individuals applying for a waiver of
the job offer requirement if the waiver
is deemed to be in the national interest.
DATES: Written comments must be
submitted to the office listed in the
SUMMARY:
E:\FR\FM\05MYN1.SGM
05MYN1
Agencies
[Federal Register Volume 79, Number 86 (Monday, May 5, 2014)]
[Notices]
[Pages 25620-25621]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10202]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-378]
Controlled Substances: Adjustment to the Established 2014
Aggregate Production Quota for Marijuana
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Notice with request for comments.
-----------------------------------------------------------------------
SUMMARY: This notice adjusts the established 2014 aggregate production
quota for marijuana, a schedule I controlled substance under the
Controlled Substances Act.
DATES: Effective date: May 5, 2014. Comment date: Interested persons
may file written comments on this notice in accordance with 21 CFR
1303.13. Electronic comments must be submitted and written comments
must be postmarked, on or before June 4, 2014. Commenters should be
aware that the electronic Federal Docket Management System will not
accept comments after midnight Eastern Time on the last day of the
comment period.
ADDRESSES: To ensure proper handling of comments, please reference
``Docket No. DEA-378'' on all electronic and written correspondence.
The DEA encourages that all comments be submitted electronically
through the Federal eRulemaking Portal which provides the ability to
type short comments directly into the comment field on the Web page or
attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for
submitting comments. Paper comments that duplicate electronic
submissions are not necessary. Should you, however, wish to submit
written comments, in lieu of electronic comments, they should be sent
via regular or express mail to: Drug Enforcement Administration,
Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette
Drive, Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT: Ruth A. Carter, Office of Diversion
Control, Drug Enforcement Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia 22152, Telephone: (202) 598-
6812.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received in response to this docket
are considered part of the public record and will be made available for
public inspection online at https://www.regulations.gov. Such
information includes personal identifying information (such as your
name, address, etc.) voluntarily submitted by the commenter.
The Freedom of Information Act (FOIA) applies to all comments
received. If you want to submit personal identifying information (such
as your name, address, etc.) as part of your comment, but do not want
it to be made publicly available, you must include the phrase
``PERSONAL IDENTIFYING INFORMATION'' in the first paragraph of your
comment. You must also place all of the personal identifying
information you do not want made publicly available in the first
paragraph of your comment and identify what information you want
redacted. If you want to submit confidential business information as
part of your comment, but do not want it to be made publicly available,
you must include the phrase ``CONFIDENTIAL BUSINESS INFORMATION'' in
the first paragraph of your comment. You must also prominently identify
the confidential business information to be redacted within the
comment. If a comment has so much confidential business information
that it cannot be effectively redacted, all or part of that comment may
not be made publicly available. Comments containing personal
identifying information or confidential business information identified
as directed above will be made publicly available in redacted form.
An electronic copy of this document is available at https://www.regulations.gov for easy reference. If you wish to personally
inspect the comments and materials received or the supporting
information the DEA used in preparing this action, these materials will
be available for public inspection by appointment. To arrange a
viewing, please see the FOR FURTHER INFORMATION CONTACT paragraph
above.
Pursuant to 21 CFR 1303.13, any interested person may submit
written comments on or objections to this notice. Based on comments
received in response to this notice, the Administrator may hold a
public hearing on one or more issues raised in the comments and
objections filed. In the event the Administrator decides to hold such a
hearing, the Administrator shall publish notice of the hearing in the
Federal Register. After consideration of any comments or objections, or
after a hearing, if one is held, the Administrator shall issue and
publish in the Federal Register a notice regarding the adjustment to
the established 2014 aggregate production quota for marijuana.\1\
---------------------------------------------------------------------------
\1\ Note that ``marihuana'' is the spelling originally used in
the Controlled Substances Act (CSA). This document uses the spelling
that is more common in current usage, ``marijuana.''
---------------------------------------------------------------------------
Legal Authority
The Drug Enforcement Administration (DEA) implements and enforces
titles II and III of the Comprehensive Drug Abuse Prevention and
Control Act of 1970, as amended. Titles II and III are referred to as
the ``Controlled Substances Act'' and the ``Controlled Substances
Import and Export Act,'' respectively, and are collectively referred to
as the ``Controlled Substances Act'' or the ``CSA'' for the purpose of
this action. 21 U.S.C. 801-971. The DEA publishes the implementing
regulations for these statutes in title 21 of the Code of Federal
Regulations (CFR), parts 1300 to 1321. The CSA and its implementing
regulations are designed to prevent, detect, and eliminate the
diversion of controlled substances and listed chemicals into the
illicit market while providing for the legitimate medical, scientific,
research, and industrial needs of the United States. Controlled
substances have the potential for abuse
[[Page 25621]]
and dependence and are controlled to protect the public health and
safety.
Section 306 of the CSA (21 U.S.C. 826) requires the Attorney
General to establish aggregate production quotas for each basic class
of controlled substance listed in schedules I and II each year. The
Attorney General has delegated this authority under 21 U.S.C. 826 to
the Administrator of the DEA, 28 CFR 0.100.
Background
The DEA established the initial 2014 aggregate production quotas
and assessments for annual need on September 9, 2013 (78 FR 55099). The
notice stipulated that, as provided for in 21 CFR 1303.13, all
aggregate production quotas and assessments for annual need are subject
to adjustment.
Analysis for Adjusting the Established 2014 Aggregate Production Quota
for Marijuana Effective on the Date of Publication
In determining to adjust the aggregate production quota, the DEA
takes into consideration, among other factors, the relevant scientific
and research needs of the United States. 21 U.S.C. 826; 21 CFR
1303.13(b)(5).
The National Institute on Drug Abuse (NIDA) is a component of the
National Institutes of Health and the U.S. Department of Health and
Human Services, and it oversees the cultivation, production and
distribution of research-grade marijuana on behalf of the United States
Government, pursuant to the Single Convention on Narcotic Drugs (March
30, 1961, 18 UST 1407). NIDA recently notified the DEA that it required
additional supplies of marijuana to be manufactured in 2014 to provide
for current and anticipated research efforts involving marijuana.
Specifically, NIDA stated that 600 kilograms is necessary to be
manufactured in 2014.
The DEA was unaware of NIDA's additional need at the time the
initial aggregate production quota for marijuana was established in
September 2013.
The aggregate production quota for marijuana should be increased in
order to provide a continuous and uninterrupted supply of marijuana in
support of DEA-registered researchers who are approved by the Federal
Government to utilize marijuana in their research protocols.
In the event the established aggregate production quota is
increased, DEA regulations require general notice of the adjustment
prior to adjusting the quota. 21 CFR 1303.13(c). Due to the
manufacturing process unique to marijuana, including the length of time
and conditions necessary to propagate and process the substance for
distribution in 2014, it is necessary to adjust the initial,
established 2014 aggregate production quota for marijuana as soon as
practicable. Accordingly, the Administrator finds good cause to adjust
the aggregate production quota for marijuana before accepting written
comments from interested persons or holding a public hearing, pursuant
to 21 CFR 1303.13(c). More specifically, the Administrator finds, based
on NIDA's aforementioned submission to DEA, that it is in the public
interest to adjust the aggregate production quota immediately to ensure
that the cultivation of marijuana to meet NIDA's anticipated needs to
supply researchers can proceed within the current grow cycle. For this
same reason, the Administrator finds that delaying the adjustment to
the aggregate production quota for marijuana until after the comment
period would be impracticable. Any such comments shall be considered if
submitted in accordance with the procedures described herein.
In issuing this adjustment, the DEA has taken into account the
criteria that the DEA is required to consider in accordance with 21 CFR
1303.13(b). The DEA determines whether to adjust the aggregate
production quotas for basic classes of schedule I and II controlled
substances by considering: (1) Changes in demand for the basic class,
changes in the national rate of net disposal for the class, and changes
in the rate of net disposal by the registrants holding individual
manufacturing quotas for the class; (2) whether any increased demand or
changes in the national or individual rates of net disposal are
temporary, short term, or long term; (3) whether any increased demand
can be met through existing inventories, increased individual
manufacturing quotas, or increased importation, without increasing the
aggregate production quota; (4) whether any decreased demand will
result in excessive inventory accumulation by all persons registered to
handle the class; and (5) other factors affecting the medical,
scientific, research, and industrial needs of the United States and
lawful export requirements, as the Administrator finds relevant.
Based on the above, the Administrator adjusts the established 2014
aggregate production quota for marijuana, to be manufactured in the
United States in 2014 to provide for the estimated scientific,
research, and industrial needs of the United States, and the
establishment and maintenance of reserve stocks, expressed in grams of
anhydrous acid or base, as follows:
------------------------------------------------------------------------
Previously
established Adjusted
Basic class--schedule I 2014 quota 2014 Quota
(g) (g)
------------------------------------------------------------------------
Marijuana................................... 21,000 650,000
------------------------------------------------------------------------
Dated: April 29, 2014.
Michele M. Leonhart,
Administrator.
[FR Doc. 2014-10202 Filed 5-2-14; 8:45 am]
BILLING CODE 4410-09-P